Natural vitamin E α-tocotrienol: Retention in vital organs in response to long-term oral supplementation and withdrawal

References

• Sen CK, Khanna S, Roy S. Tocotrienol: The natural vitamin E to defend the nervous system?. Ann N Y Acad Sci 2004; 1031: 127–142
   PubMed Web of Science ®Google Scholar
• Sen CK, Khanna S, Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci 2006, in press
   PubMedGoogle Scholar
• Traber MG, Burton GW, Hamilton RL. Vitamin E trafficking. Ann N Y Acad Sci 2004; 1031: 1–12
   PubMed Web of Science ®Google Scholar
• Khanna S, Patel V, Rink C, Roy S, Sen CK. Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic Biol Med 2005; 39: 1310–1319
   PubMed Web of Science ®Google Scholar
• Schaffer S, Muller WE, Eckert GP. Tocotrienols: Constitutional effects in aging and disease. J Nutr 2005; 135: 151–154
   PubMed Web of Science ®Google Scholar
• Pearce BC, Parker RA, Deason ME, Dischino DD, Gillespie E, Qureshi AA, Volk K, Wright JJ. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J Med Chem 1994; 37: 526–541
   PubMed Web of Science ®Google Scholar
• Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJ. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem 1992; 35: 3595–3606
   PubMed Web of Science ®Google Scholar
• Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alphatocotrienol. Free Radic Biol Med 1991; 10: 263–275
   PubMed Web of Science ®Google Scholar
• Serbinova EA, Packer L. Antioxidant properties of alpha-tocopherol and alphatocotrienol. Methods Enzymol 1994; 234: 354–366
   PubMed Web of Science ®Google Scholar
• Suzuki YJ, Tsuchiya M, Wassall SR, Choo YM, Govil G, Kagan VE, Packer L. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: Implication to the molecular mechanism of their antioxidant potency. Biochemistry 1993; 32: 10692–10699
   PubMed Web of Science ®Google Scholar
• Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M, Miyazawa T. Anti-angiogenic activity of tocotrienol. Biosci Biotechnol Biochem 2003; 67: 1623–1627
   PubMed Web of Science ®Google Scholar
• Miyazawa T, Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M. Anti-angiogenic potential of tocotrienol in vitro. Biochemistry (Mosc) 2004; 69: 67–69
   PubMedGoogle Scholar
• Blatt DH, Leonard SW, Traber MG. Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 2001; 17: 799–805
   PubMed Web of Science ®Google Scholar
• Kaempf-Rotzoll DE, Traber MG, Arai H. Vitamin E and transfer proteins. Curr Opin Lipidol 2003; 14: 249–254
   PubMed Web of Science ®Google Scholar
• Traber MG, Arai H. Molecular mechanisms of vitamin E transport. Annu Rev Nutr 1999; 19: 343–355
   PubMed Web of Science ®Google Scholar
• Stocker A. Molecular mechanisms of vitamin E transport. Ann N Y Acad Sci 2004; 1031: 44–59
   PubMed Web of Science ®Google Scholar
• Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 1997; 409: 105–108
   PubMed Web of Science ®Google Scholar
• Panagabko C, Morley S, Hernandez M, Cassolato P, Gordon H, Parsons R, Manor D, Atkinson J. Ligand specificity in the CRAL-TRIO protein family. Biochemistry 2003; 42: 6467–6474
   PubMedGoogle Scholar
• Podda M, Weber C, Traber MG, Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J Lipid Res 1996; 37: 893–901
   PubMed Web of Science ®Google Scholar
• Roy S, Lado BH, Khanna S, Sen CK. Vitamin E sensitive genes in the developing rat fetal brain: A high-density oligonucleotide microarray analysis. FEBS Lett 2002; 530: 17–23
   PubMed Web of Science ®Google Scholar
• Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, Sen CK. Molecular basis of vitamin E action: Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 2003; 278: 43508–43515
   PubMed Web of Science ®Google Scholar
• Sen CK, Khanna S, Roy S, Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem 2000; 275: 13049–13055
   PubMed Web of Science ®Google Scholar
• Khanna S, Roy S, Slivka A, Craft TKS, Chaki S, Rink C, Notestine MA, DeVries AC, Parinandi NL, Sen CK. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005; 36: 2258–2264
   PubMed Web of Science ®Google Scholar
• O'Byrne D, Grundy S, Packer L, Devaraj S, Baldenius K, Hoppe PP, Kraemer K, Jialal I, Traber MG. Studies of LDL oxidation following alpha-, gamma-, or deltatocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic Biol Med 2000; 29: 834–845
   PubMed Web of Science ®Google Scholar
• Khosla P, Patel V, Whinter J, Khanna S, Rakhkovskaya M, Roy S, Sen CK. Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 2006; 8, in press
   PubMedGoogle Scholar
• van der Worp HB, Bar PR, Kappelle LJ, de Wildt DJ. Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats. Stroke 1998; 29: 1002–1005, discussion 1005–1006
   PubMed Web of Science ®Google Scholar
• Roy S, Venojarvi M, Khanna S, Sen CK. Simultaneous detection of tocopherols and tocotrienols in biological samples using HPLC-coulometric electrode array. Methods Enzymol 2002; 352: 326–332
   PubMedGoogle Scholar
• Adachi K, Miki M, Tamai H, Tokuda M, Mino M. Adipose tissues and vitamin E. J Nutr Sci Vitaminol (Tokyo) 1990; 36: 327–337
   PubMed Web of Science ®Google Scholar
• Garry PJ, Hunt WC, Bandrofchak JL, VanderJagt D, Goodwin JS. Vitamin A intake and plasma retinol levels in healthy elderly men and women. Am J Clin Nutr 1987; 46: 989–994
   PubMed Web of Science ®Google Scholar
• Lodge JK, Hall WL, Jeanes YM, Proteggente AR. Physiological factors influencing vitamin E biokinetics. Ann N Y Acad Sci 2004; 1031: 60–73
   PubMed Web of Science ®Google Scholar
• Aten RF, Kolodecik TR, Behrman HR. Ovarian vitamin E accumulation: Evidence for a role of lipoproteins. Endocrinology 1994; 135: 533–539
   PubMedGoogle Scholar
• Datta S, Wang L, Moore DD, Osborne TF. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter by nuclear receptors liver receptor homologue-1 and small heterodimer partner: A mechanism for differential regulation of cholesterol synthesis and uptake. J Biol Chem 2006; 281: 807–812
   PubMedGoogle Scholar
• Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005; 182: 367–374
   PubMed Web of Science ®Google Scholar
• Traber MG, Sies H. Vitamin E in humans: Demand and delivery. Annu Rev Nutr 1996; 16: 321–347
   PubMed Web of Science ®Google Scholar
• Cuddihy SL, Musiek ES, Morrow JD, Dugan LL. Long-term vitamin E deficiency in mice decreases superoxide radical production in brain. Ann N Y Acad Sci 2004; 1031: 428–431
   PubMedGoogle Scholar
• Birringer M, Pfluger P, Kluth D, Landes N, Brigelius-Flohe R. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J Nutr 2002; 132: 3113–3118
   PubMed Web of Science ®Google Scholar
• Packer L, Weber SU, Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr 2001; 131: 369S–373S
   PubMed Web of Science ®Google Scholar
• Yap SP, Yuen KH, Wong JW. Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 2001; 53: 67–71
   PubMed Web of Science ®Google Scholar
• Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Tetu B, Harel F, Masse B, Vigneault E, Vass S, del Vecchio P, Roy J. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005; 97: 481–488
   PubMed Web of Science ®Google Scholar
• Miller ER, 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37–46
   PubMed Web of Science ®Google Scholar
• Devaraj S, Jialal I. Failure of vitamin E in clinical trials: Is gamma-tocopherol the answer?. Nutr Rev 2005; 63: 290–293
   PubMed Web of Science ®Google Scholar
• Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ, Floyd RA. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med 2004; 36: 1–15
   PubMed Web of Science ®Google Scholar